Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoride uptake and remineralisation of incipient carious lesions with different fluoride concentrations
2004-002366-38Phase 4Completed
- Sponsor
- Colgate-Palmolive
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of olaflur + dectaflur in carious lesion (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: Fluoride uptake and Remineralisation of incipient carious lesions. Started Oct 2004; status: completed.
02
Drugs
olaflur + dectaflur
03
Conditions
carious lesion
Beyond the preview
Go deeper on 2004-002366-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002366-38.